Selected research
Market Structure
Global Transdermal Skin Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Transdermal Skin Patches market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Transdermal Skin Patches include Hisamitsu Pharmaceutical, Luye Pharma Group, Mundipharma International, Purdue Pharma, Mylan N.V., Novartis AG, Johnson & Johnson and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Transdermal Skin Patches market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Transdermal Skin Patches and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Transdermal Skin Patches sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transdermal Skin Patches market size, projected growth trends, production technologies, key applications, and end-use industries.
Transdermal Skin Patches Segment by Company
Hisamitsu Pharmaceutical
Luye Pharma Group
Mundipharma International
Purdue Pharma
Mylan N.V.
Novartis AG
Johnson & Johnson
Teva Pharmaceutical Industries
Transdermal Skin Patches Segment by Type
Drug in Adhesive
Reservoir
Vapor
Matrix
Others
Transdermal Skin Patches Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Transdermal Skin Patches Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Transdermal Skin Patches market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Skin Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal Skin Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Transdermal Skin Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Drug in Adhesive
- Reservoir
- Vapor
- Matrix
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Hisamitsu Pharmaceutical
- Luye Pharma Group
- Mundipharma International
- Purdue Pharma
- Mylan N.V.
- Novartis AG
- Johnson & Johnson
- Teva Pharmaceutical Industries
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Transdermal Skin Patches Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Transdermal Skin Patches Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Transdermal Skin Patches Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Transdermal Skin Patches Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Transdermal Skin Patches Market Dynamics
- 2.1 Transdermal Skin Patches Industry Trends
- 2.2 Transdermal Skin Patches Industry Drivers
- 2.3 Transdermal Skin Patches Industry Opportunities and Challenges
- 2.4 Transdermal Skin Patches Industry Restraints
3 Transdermal Skin Patches Market by Manufacturers
- 3.1 Global Transdermal Skin Patches Revenue by Manufacturers (2021-2026)
- 3.2 Global Transdermal Skin Patches Sales by Manufacturers (2021-2026)
- 3.3 Global Transdermal Skin Patches Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Transdermal Skin Patches Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Transdermal Skin Patches Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Transdermal Skin Patches Manufacturers, Product Type & Application
- 3.7 Global Transdermal Skin Patches Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Transdermal Skin Patches Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Transdermal Skin Patches Players Market Share by Revenue in 2025
- 3.8.3 2025 Transdermal Skin Patches Tier 1, Tier 2, and Tier 3
4 Transdermal Skin Patches Market by Type
- 4.1 Transdermal Skin Patches Type Introduction
- 4.1.1 Drug in Adhesive
- 4.1.2 Reservoir
- 4.1.3 Vapor
- 4.1.4 Matrix
- 4.1.5 Others
- 4.2 Global Transdermal Skin Patches Sales by Type
- 4.2.1 Global Transdermal Skin Patches Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Transdermal Skin Patches Sales by Type (2021-2032)
- 4.2.3 Global Transdermal Skin Patches Sales Market Share by Type (2021-2032)
- 4.3 Global Transdermal Skin Patches Revenue by Type
- 4.3.1 Global Transdermal Skin Patches Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Transdermal Skin Patches Revenue by Type (2021-2032)
- 4.3.3 Global Transdermal Skin Patches Revenue Market Share by Type (2021-2032)
5 Transdermal Skin Patches Market by Application
- 5.1 Transdermal Skin Patches Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Transdermal Skin Patches Sales by Application
- 5.2.1 Global Transdermal Skin Patches Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Transdermal Skin Patches Sales by Application (2021-2032)
- 5.2.3 Global Transdermal Skin Patches Sales Market Share by Application (2021-2032)
- 5.3 Global Transdermal Skin Patches Revenue by Application
- 5.3.1 Global Transdermal Skin Patches Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Transdermal Skin Patches Revenue by Application (2021-2032)
- 5.3.3 Global Transdermal Skin Patches Revenue Market Share by Application (2021-2032)
6 Global Transdermal Skin Patches Sales by Region
- 6.1 Global Transdermal Skin Patches Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Transdermal Skin Patches Sales by Region (2021-2032)
- 6.2.1 Global Transdermal Skin Patches Sales by Region (2021-2026)
- 6.2.2 Global Transdermal Skin Patches Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Transdermal Skin Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Transdermal Skin Patches Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Transdermal Skin Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Transdermal Skin Patches Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Transdermal Skin Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Transdermal Skin Patches Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Transdermal Skin Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Transdermal Skin Patches Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Transdermal Skin Patches Revenue by Region
- 7.1 Global Transdermal Skin Patches Revenue by Region
- 7.1.1 Global Transdermal Skin Patches Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Transdermal Skin Patches Revenue by Region (2021-2026)
- 7.1.3 Global Transdermal Skin Patches Revenue by Region (2027-2032)
- 7.1.4 Global Transdermal Skin Patches Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Transdermal Skin Patches Revenue (2021-2032)
- 7.2.2 North America Transdermal Skin Patches Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Transdermal Skin Patches Revenue (2021-2032)
- 7.3.2 Europe Transdermal Skin Patches Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Transdermal Skin Patches Revenue (2021-2032)
- 7.4.2 Asia-Pacific Transdermal Skin Patches Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Transdermal Skin Patches Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Transdermal Skin Patches Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Hisamitsu Pharmaceutical
- 8.1.1 Hisamitsu Pharmaceutical Company Information
- 8.1.2 Hisamitsu Pharmaceutical Business Overview
- 8.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patches Product Portfolio
- 8.1.5 Hisamitsu Pharmaceutical Recent Developments
- 8.2 Luye Pharma Group
- 8.2.1 Luye Pharma Group Company Information
- 8.2.2 Luye Pharma Group Business Overview
- 8.2.3 Luye Pharma Group Transdermal Skin Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Luye Pharma Group Transdermal Skin Patches Product Portfolio
- 8.2.5 Luye Pharma Group Recent Developments
- 8.3 Mundipharma International
- 8.3.1 Mundipharma International Company Information
- 8.3.2 Mundipharma International Business Overview
- 8.3.3 Mundipharma International Transdermal Skin Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Mundipharma International Transdermal Skin Patches Product Portfolio
- 8.3.5 Mundipharma International Recent Developments
- 8.4 Purdue Pharma
- 8.4.1 Purdue Pharma Company Information
- 8.4.2 Purdue Pharma Business Overview
- 8.4.3 Purdue Pharma Transdermal Skin Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Purdue Pharma Transdermal Skin Patches Product Portfolio
- 8.4.5 Purdue Pharma Recent Developments
- 8.5 Mylan N.V.
- 8.5.1 Mylan N.V. Company Information
- 8.5.2 Mylan N.V. Business Overview
- 8.5.3 Mylan N.V. Transdermal Skin Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Mylan N.V. Transdermal Skin Patches Product Portfolio
- 8.5.5 Mylan N.V. Recent Developments
- 8.6 Novartis AG
- 8.6.1 Novartis AG Company Information
- 8.6.2 Novartis AG Business Overview
- 8.6.3 Novartis AG Transdermal Skin Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Novartis AG Transdermal Skin Patches Product Portfolio
- 8.6.5 Novartis AG Recent Developments
- 8.7 Johnson & Johnson
- 8.7.1 Johnson & Johnson Company Information
- 8.7.2 Johnson & Johnson Business Overview
- 8.7.3 Johnson & Johnson Transdermal Skin Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Johnson & Johnson Transdermal Skin Patches Product Portfolio
- 8.7.5 Johnson & Johnson Recent Developments
- 8.8 Teva Pharmaceutical Industries
- 8.8.1 Teva Pharmaceutical Industries Company Information
- 8.8.2 Teva Pharmaceutical Industries Business Overview
- 8.8.3 Teva Pharmaceutical Industries Transdermal Skin Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Teva Pharmaceutical Industries Transdermal Skin Patches Product Portfolio
- 8.8.5 Teva Pharmaceutical Industries Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Transdermal Skin Patches Value Chain Analysis
- 9.1.1 Transdermal Skin Patches Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Transdermal Skin Patches Production Mode & Process
- 9.2 Transdermal Skin Patches Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Transdermal Skin Patches Distributors
- 9.2.3 Transdermal Skin Patches Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst